Our previous work comparing high and low NOS2 and COX2 (also known as PTGS2) tumor expression revealed associations with a variety of inflammatory markers that are typically associated with antitumor activity [10], which prompted us to explore cytokine regulatory effects on NOS2/COX2 expression in tumor cells and tissues. The gene discussed is PTGS2; the disease is neoplasm.